grazoprevir

drug approved for the treatment of hepatitis C

Uses your system voice; voice and rate in settings.

Q19786991Snapshot

≈ 2 min read

Names in other languages

  • العربيةغرازوبريفير
  • DeutschGrazoprevir
  • Englishgrazoprevir
  • EspañolGrazoprevir
  • ItalianoGrazoprevir
  • Polskigrazoprewir
  • РусскийГразопревир
  • Tiếng ViệtGrazoprevir

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Grazoprevir is a drug approved for the treatment of hepatitis C. It was developed by Merck and completed Phase III trials, used in combination with the NS5A replication complex inhibitor elbasvir under the trade name Zepatier, either with or without ribavirin. Grazoprevir is a second generation hepatitis C virus protease inhibitor acting at the NS3/4A protease targets.

It has good activity against a range of HCV genotype variants, including some that are resistant to most currently used antiviral medications.

Side effects

Side effects have only been assessed in the combination with elbasvir. Common side effects of the combination include feeling tired, nausea, reduced appetite, and headache. Low red blood cell count has occurred when co-administered with ribavirin in some cases. The most important risks are alanine transaminase elevation, hyperbilirubinemia, drug resistance development and drug interactions.

Mechanism of action

Grazoprevir blocks NS3, a serine protease enzyme the virus needs for splitting its polyprotein into the functional virus proteins, and NS4A, a cofactor of NS3.

Pharmacokinetics

Grazoprevir reaches peak plasma concentrations two hours after oral intake together with elbasvir (variation between patients: 30 minutes to three hours). In hepatitis C patients, steady state concentrations are found after about six days. Plasma protein binding is 98.8%, mainly to albumin and alpha-1-acid glycoprotein.

Part of the substance is oxidised in the liver, largely by the enzyme CYP3A4. The biological half-life is 31 hours on average. Over 90% are excreted via the faeces, and less than 1% via the urine.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1363943243 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.